GB2442161B - Triglycerides - Google Patents
TriglyceridesInfo
- Publication number
- GB2442161B GB2442161B GB0724618A GB0724618A GB2442161B GB 2442161 B GB2442161 B GB 2442161B GB 0724618 A GB0724618 A GB 0724618A GB 0724618 A GB0724618 A GB 0724618A GB 2442161 B GB2442161 B GB 2442161B
- Authority
- GB
- United Kingdom
- Prior art keywords
- triglycerides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000003626 triacylglycerols Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
- C07C69/587—Monocarboxylic acid esters having at least two carbon-to-carbon double bonds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0724618A GB2442161B (en) | 2003-08-18 | 2004-08-13 | Triglycerides |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0319358A GB0319358D0 (en) | 2003-08-18 | 2003-08-18 | Treatment of neurodegenerative conditions |
GB0410846A GB0410846D0 (en) | 2004-05-14 | 2004-05-14 | Treatment of neurodegenerative conditions |
GB0603646A GB2422373B (en) | 2003-08-18 | 2004-08-13 | Treatment of neurodegenerative conditions |
GB0724618A GB2442161B (en) | 2003-08-18 | 2004-08-13 | Triglycerides |
Publications (3)
Publication Number | Publication Date |
---|---|
GB0724618D0 GB0724618D0 (en) | 2008-01-30 |
GB2442161A GB2442161A (en) | 2008-03-26 |
GB2442161B true GB2442161B (en) | 2008-05-21 |
Family
ID=39126167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0724618A Expired - Fee Related GB2442161B (en) | 2003-08-18 | 2004-08-13 | Triglycerides |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2442161B (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4058594A (en) * | 1974-04-25 | 1977-11-15 | John Williams | Immuno-suppressive agents |
WO2001097793A2 (en) * | 2000-06-23 | 2001-12-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | 2-arachidonylglycerol (2-ag) - an inhibitor of tumor necrosis factor -alfa and neuroprotector of brain in closed head injury |
WO2003013497A1 (en) * | 2001-08-02 | 2003-02-20 | Suntory Limited | Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction |
GB2415378A (en) * | 2003-05-14 | 2005-12-28 | Btg Int Ltd | Use of triglyceride oils containing gamma-linolenic acid residues and linolenic acid residues for the treatment of neurogenerative disease |
-
2004
- 2004-08-13 GB GB0724618A patent/GB2442161B/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4058594A (en) * | 1974-04-25 | 1977-11-15 | John Williams | Immuno-suppressive agents |
WO2001097793A2 (en) * | 2000-06-23 | 2001-12-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | 2-arachidonylglycerol (2-ag) - an inhibitor of tumor necrosis factor -alfa and neuroprotector of brain in closed head injury |
WO2003013497A1 (en) * | 2001-08-02 | 2003-02-20 | Suntory Limited | Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction |
GB2415378A (en) * | 2003-05-14 | 2005-12-28 | Btg Int Ltd | Use of triglyceride oils containing gamma-linolenic acid residues and linolenic acid residues for the treatment of neurogenerative disease |
Also Published As
Publication number | Publication date |
---|---|
GB2442161A (en) | 2008-03-26 |
GB0724618D0 (en) | 2008-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1615948A4 (en) | Immuno-amplification | |
EP1635758A4 (en) | Orthodynamic rehabilitator | |
DE502004011703D1 (en) | N-heterocyclyl-phenylsubstituierte cyclische ketoenole | |
DE602004012071D1 (en) | T-hilfe | |
DE602004020356D1 (en) | Phenoxyessigsäurederivate | |
DE602004030538D1 (en) | Präzisionssubstratlagerbehälter | |
EP1629178A4 (en) | Rockbolt | |
DE502004009243D1 (en) | Spirocyclische cyclohexan-derivate | |
DE602004027010D1 (en) | Thermotherapiehülle | |
DE502004003476D1 (en) | Standfuss | |
DE502004006683D1 (en) | Injection-locked-oscillator-schaltkreis | |
DE502004004146D1 (en) | Pyrazolverbindungen | |
DE112004002769D2 (en) | Schienengeführtes transportsystem | |
DK1665437T3 (en) | Reformeringsmodul | |
DE60333037D1 (en) | Laser-radar | |
DE502004011343D1 (en) | Rotorspinnmaschine | |
DE602004012262D1 (en) | Benzimidazolonverbindung | |
DE602004020525D1 (en) | Imidazolderivate | |
DE10394343D2 (en) | Berührungslose biometrische erkennung | |
HU2598U (en) | Quick-joint | |
DE602004009041D1 (en) | Hydroxytetrahydronaphthalenylharnstoffderivate | |
GB0326454D0 (en) | Magik top | |
DE602004008281D1 (en) | Avermectin-b1-monosaccharidderivative | |
GB2442161B (en) | Triglycerides | |
EP1698434A4 (en) | Geinder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
732E | Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977) |
Free format text: REGISTERED BETWEEN 20120927 AND 20121003 |
|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20220813 |